Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.

Lopez-Beltran A, Qian J, Montironi R, Luque RJ, Bostwick DG.

Int J Surg Pathol. 2005 Apr;13(2):167-73.

PMID:
15864380
2.

Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.

López-Beltrán A, Artacho-Pérula E, Luque-Barona RJ, Roldán-Villalobos R.

Anal Quant Cytol Histol. 2000 Dec;22(6):438-44.

PMID:
11147297
3.
5.

Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.

Yokozaki M, Kodama T, Yokose T, Matsumoto T, Mukai K.

Mod Pathol. 1996 Dec;9(12):1156-64.

PMID:
8972475
6.

Is atypical adenomatous hyperplasia of the prostate a precursor lesion?

Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L.

Prostate. 2011 Dec;71(16):1746-51. doi: 10.1002/pros.21391. Epub 2011 Apr 7.

PMID:
21480308
7.

Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.

Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH.

Hum Pathol. 1993 Aug;24(8):819-32.

PMID:
8375853
8.

Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?

Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG.

Cancer Res. 1998 Feb 1;58(3):389-91.

9.

Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.

Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D, Bostwick D.

Pathologica. 1997 Jun;89(3):288-300.

PMID:
9270265
10.
11.

Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.

Mazzucchelli R, Scarpelli M, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R.

Cell Oncol (Dordr). 2013 Feb;36(1):37-42. doi: 10.1007/s13402-012-0111-7. Epub 2012 Nov 7.

PMID:
23132460
12.

Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.

Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z.

Am J Surg Pathol. 2002 Jul;26(7):921-5.

PMID:
12131160
13.
15.

Atypical adenomatous hyperplasia of the prostate: a critical review.

Grignon DJ, Sakr WA.

Eur Urol. 1996;30(2):206-11. Review.

PMID:
8875202
16.

Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.

Mirtti T, Kallajoki M, Aaltonen M, Alanen K.

Anal Quant Cytol Histol. 2001 Jun;23(3):229-37.

PMID:
11444193
18.

Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.

Stamatiou K, Alevizos A, Natzar M, Mihas C, Mariolis A, Michalodimitrakis E, Sofras F.

Asian J Androl. 2007 Mar;9(2):229-33. Epub 2006 Jun 5.

19.
20.

Supplemental Content

Support Center